Radiation therapy is a common treatment for painful bone metastases, proving effective in 1 to 2/3 of cases after 1 to 10 sessions, with stereotactic body radiation therapy (SBRT) likely offering superior results.
Radiation therapy is also used to prevent bone events, although its use is not standardized; the decision to administer it is made by clinicians or through multidisciplinary team (MDT) discussions.
Recently, it has been shown that preventive radiation therapy can reduce the risk of skeletal-related events (SREs) in patients at high risk for bone events.
The objective is to compare active surveillance with preventive radiation therapy in patients at intermediate risk for bone events.
Inclusion Criteria:
Exclusion Criteria:
sebastien.thureau@chb.unicancer.fr
no bone radiation for patient allocated in this arm
patient undergo prophylactic radiation on bone metastases
doriane.richard@chb.unicancer.fr+33232082985
sebastien.thureau@chb.unicancer.fr+33232082985
Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers
Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
Post-operative RadioTherapy for Patients With Metastases of the Long Bones
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease